C57BL/6N-Col11a1em2(IMPC)Wtsi/WtsiCnbc
Status | Available to order |
EMMA ID | EM:14562 |
International strain name | C57BL/6N-Col11a1em2(IMPC)Wtsi/WtsiCnbc |
Alternative name | |
Strain type | Endonuclease-mediated |
Allele/Transgene symbol | Col11a1em2(IMPC)Wtsi |
Gene/Transgene symbol | Col11a1 |
Information from provider
Provider | Wellcome Trust Sanger Institute |
Provider affiliation | Wellcome Trust Sanger Institute |
Genetic information | This mouse line originates from CRISPR zygote microinjection. For further details see the project page at the IMPC portal. |
Phenotypic information | Potential phenotyping data in the IMPC portal |
References | None available |
Information from EMMA
Archiving centre | CNB-CSIC, Centro Nacional de Biotecnologia, Madrid, Spain |
Animals used for archiving | heterozygous C57BL/6N |
Disease and phenotype information
Orphanet associated rare diseases, based on orthologous gene matching
- Fibrochondrogenesis / Orphanet_2021
- Autosomal dominant myopia-midfacial retrusion-sensorineural hearing loss-rhizomelic dysplasia syndrome / Orphanet_440354
- Marshall syndrome / Orphanet_560
- Autosomal recessive Stickler syndrome / Orphanet_250984
- Stickler syndrome type 2 / Orphanet_90654
IMPC phenotypes (gene matching)
Information on how we integrate external resources can be found here
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).